Mahima Datla vs Dr. Renuka Datla & Ors. (with connected appeals of Purnima Mantena and Indira Pusapati)
Background
This was a family dispute over control of Biological E. Ltd., a pharmaceutical/vaccine company, between Dr. Renuka Datla (widow of the company's late Chairman, Dr. Vijay Kumar Datla) and her three daughters (Mahima Datla, Purnima Mantena and Indira Pusapati). After Dr. Vijay Kumar Datla's death, his 81% shareholding was transferred to daughter Mahima Datla based on a 2005 Will, and she was made Managing Director through a series of Board meetings the mother did not attend; the mother separately claimed ownership of those shares under an earlier 1987 Will (litigated in a pending civil suit) and alleged the meetings and share transfer were oppressive and designed to dilute her rights. The Company Law Board dismissed her company-law petition as not maintainable and on merits, but the Telangana High Court reversed that and granted her relief, including one-fourth of the disputed shares and continued directorships for her nominees, prompting the daughters' appeal to the Supreme Court.
Decision Breakdown
The Supreme Court held the High Court had erred on multiple counts: it wrongly decided a pure question of inheritance (who owns the disputed shares under which Will) inside a company-oppression proceeding, when that question was already pending before a civil court in a separate suit: settled law holds that title disputes are not the proper subject of an oppression/mismanagement petition. The High Court's direction letting the mother's nominee-directors hold office for three years also violated the statutory one-third annual retirement-by-rotation rule under Section 152(6) of the Companies Act and the company's own Articles of Association, and its finding of "oppression" was unsupported since there was no evidence the company's affairs were run against public interest (the company was in fact running profitably, including through the COVID pandemic). Rather than deciding every point to its logical, adversarial end, the Court noted that the daughters, in court, voluntarily offered generous ongoing financial support and honorary status to their 75-year-old mother; recording this, the Court set aside the High Court's judgment, restored the Company Law Board's original order, and added conditions requiring the company to appoint Dr. Renuka Datla as Emeritus Consultant with a monthly payment of Rs. 65 lakh, a lump-sum Rs. 10 crore payment, and other facilities (medical, security, residence, car maintenance, club memberships), with both sides undertaking to end all pending litigation and not initiate fresh proceedings against each other.
Lesson Learnt
A statutory remedy for shareholder "oppression" cannot be used as a shortcut to decide an underlying inheritance or title dispute that is already pending in a civil court: the two are legally distinct, and courts also encourage practical, amicable settlements in bitter family-business disputes rather than pressing every legal point to its harshest conclusion.